This inventor holds 1 USPTO granted patent. Top assignee: Burroughs Wellcome Co.. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: Scott H. Dickerson: Innovator in Pharmaceutical Compounds
Introduction
Scott H. Dickerson is a notable inventor based in Raleigh, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on thymidylate synthase inhibitors. His research and inventions have the potential to impact medical treatments significantly.
Latest Patents
Scott H. Dickerson holds 1 patent related to pharmaceutical compounds. His patent focuses on novel benzoquinazoline thymidylate synthase inhibitors, which are crucial for developing new pharmaceutical formulations and their applications in medicine.
Career Highlights
Scott is associated with Burroughs Wellcome Co., where he has been instrumental in advancing pharmaceutical research. His work has contributed to the understanding and development of new therapeutic agents.
Collaborations
Throughout his career, Scott has collaborated with esteemed colleagues, including Julius Vass Johnson and William Pendergast. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Scott H. Dickerson exemplifies the spirit of innovation in the pharmaceutical industry, with his work paving the way for future advancements in medicine. His contributions are a testament to the importance of research and collaboration in developing effective treatments.